{
    "name": "FDA warning letters on compounded GLP-1 marketing",
    "description": "Company, letter date, FDA reference number, products named and cited violation categories for every FDA warning letter issued to telehealth and compounding companies about compounded GLP-1 marketing.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "documentation_url": "https://dfylegitscript.com/research/glp-1-compounding-warning-letters",
    "csv_url": "https://dfylegitscript.com/data/glp-1-warning-letters.csv",
    "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters",
    "violation_categories": {
        "fda-approved-claim": "Implied the compounded drug is FDA-approved or equivalent to the brand",
        "misbranding": "Misbranding",
        "misleading-comparison": "Misleading comparison to an approved product",
        "safety-efficacy-claim": "Unsupported safety or efficacy claim",
        "unapproved-new-drug": "Unapproved new drug",
        "personalized-dosing-claim": "Unsupported \"personalized dosing\" claim",
        "omission-of-risk": "Omitted material risk information",
        "other": "Other cited violation"
    },
    "columns": [
        "company",
        "letter_date",
        "fda_reference",
        "products",
        "cited_violations",
        "wave",
        "source_url"
    ],
    "row_count": 110,
    "rows": [
        {
            "company": "Altru Telehealth, LLC dba Altru Telehealth",
            "letter_date": "2026-06-08",
            "fda_reference": "728274",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274-06082026"
        },
        {
            "company": "Amie Health, Inc. dba Amie",
            "letter_date": "2026-06-08",
            "fda_reference": "728276",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amie-health-inc-dba-amie-728276-06082026"
        },
        {
            "company": "Clover Meds LLC dba Clover Meds",
            "letter_date": "2026-06-08",
            "fda_reference": "728234",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clover-meds-llc-dba-clover-meds-728234-06082026"
        },
        {
            "company": "D&H Medical Services",
            "letter_date": "2026-06-08",
            "fda_reference": "728238",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dh-medical-services-728238-06082026"
        },
        {
            "company": "Eden Health International Inc. dba Eden",
            "letter_date": "2026-06-08",
            "fda_reference": "728279",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-06082026"
        },
        {
            "company": "Ezra Holdco LLC dba Ezra",
            "letter_date": "2026-06-08",
            "fda_reference": "730995",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ezra-holdco-llc-dba-ezra-730995-06082026"
        },
        {
            "company": "FITISH",
            "letter_date": "2026-06-08",
            "fda_reference": "728280",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitish-728280-06082026"
        },
        {
            "company": "FitRX, LLC dba AM RX",
            "letter_date": "2026-06-08",
            "fda_reference": "728275",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-06082026"
        },
        {
            "company": "Glow Medispa, LLC dba Mint Med",
            "letter_date": "2026-06-08",
            "fda_reference": "730390",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-medispa-llc-dba-mint-med-730390-06082026"
        },
        {
            "company": "HydraMed IV LLC dba HydraMed",
            "letter_date": "2026-06-08",
            "fda_reference": "728282",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydramed-iv-llc-dba-hydramed-728282-06082026"
        },
        {
            "company": "Joi and Blokes dba Joi + Blokes",
            "letter_date": "2026-06-08",
            "fda_reference": "728283",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joi-and-blokes-dba-joi-blokes-728283-06082026"
        },
        {
            "company": "Maximus Health, Inc. dba Maximus",
            "letter_date": "2026-06-08",
            "fda_reference": "730095",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026"
        },
        {
            "company": "Medica Weight Loss",
            "letter_date": "2026-06-08",
            "fda_reference": "728284",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medica-weight-loss-728284-06082026"
        },
        {
            "company": "Momentum Health 360 dba Momentum Health",
            "letter_date": "2026-06-08",
            "fda_reference": "728286",
            "products": [
                "liraglutide",
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/momentum-health-360-dba-momentum-health-728286-06082026"
        },
        {
            "company": "NativeMed LLC dba NativeMed",
            "letter_date": "2026-06-08",
            "fda_reference": "728287",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nativemed-llc-dba-nativemed-728287-06082026"
        },
        {
            "company": "Nexlife Inc. dba Nexlife",
            "letter_date": "2026-06-08",
            "fda_reference": "730096",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexlife-inc-dba-nexlife-730096-06082026"
        },
        {
            "company": "Nexus Health Solutions LLC dba Harper Meds",
            "letter_date": "2026-06-08",
            "fda_reference": "728281",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281-06082026"
        },
        {
            "company": "Nova Vascular LLC dba NOVARX",
            "letter_date": "2026-06-08",
            "fda_reference": "728290",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nova-vascular-llc-dba-novarx-728290-06082026"
        },
        {
            "company": "OrderlyMeds LLC dba OrderlyMeds",
            "letter_date": "2026-06-08",
            "fda_reference": "728291",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-06082026"
        },
        {
            "company": "Public Health Solution LLC dba DrMedHealth",
            "letter_date": "2026-06-08",
            "fda_reference": "728278",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/public-health-solution-llc-dba-drmedhealth-728278-06082026"
        },
        {
            "company": "Ready Med",
            "letter_date": "2026-06-08",
            "fda_reference": "730317",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ready-med-730317-06082026"
        },
        {
            "company": "Roen Health, Inc. dba RoenRx",
            "letter_date": "2026-06-08",
            "fda_reference": "728293",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/roen-health-inc-dba-roenrx-728293-06082026"
        },
        {
            "company": "Thrivelab Co. dba Thrivelab",
            "letter_date": "2026-06-08",
            "fda_reference": "728294",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrivelab-co-dba-thrivelab-728294-06082026"
        },
        {
            "company": "Trinity HealthCare Supply, LLC dba altRx",
            "letter_date": "2026-06-08",
            "fda_reference": "728236",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236-06082026"
        },
        {
            "company": "VivioMD Group LLC dba VivioMD",
            "letter_date": "2026-06-08",
            "fda_reference": "728295",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-06",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viviomd-group-llc-dba-viviomd-728295-06082026"
        },
        {
            "company": "24HrDoc, Inc. dba 24HrDoc",
            "letter_date": "2026-02-20",
            "fda_reference": "717984",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/24hrdoc-inc-dba-24hrdoc-717984-02202026"
        },
        {
            "company": "Alan Health Technologies Inc. dba Alan",
            "letter_date": "2026-02-20",
            "fda_reference": "721814",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alan-health-technologies-inc-dba-alan-721814-02202026"
        },
        {
            "company": "Aspen Aesthetics dba Fifty 410",
            "letter_date": "2026-02-20",
            "fda_reference": "721481",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-02202026"
        },
        {
            "company": "Belle Health LLC dba Belle",
            "letter_date": "2026-02-20",
            "fda_reference": "721795",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-02202026"
        },
        {
            "company": "Better Health Labs, Inc. dba Measured",
            "letter_date": "2026-02-20",
            "fda_reference": "721454",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/better-health-labs-inc-dba-measured-721454-02202026"
        },
        {
            "company": "Bliv Wellness LLC dba Bliv",
            "letter_date": "2026-02-20",
            "fda_reference": "721479",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bliv-wellness-llc-dba-bliv-721479-02202026"
        },
        {
            "company": "BluefitMD",
            "letter_date": "2026-02-20",
            "fda_reference": "721446",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bluefitmd-721446-02202026"
        },
        {
            "company": "Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics",
            "letter_date": "2026-02-20",
            "fda_reference": "721447",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/deluxe-iv-aesthetics-pllc-dba-deluxe-iv-and-aesthetics-721447-02202026"
        },
        {
            "company": "Dripgym Mobile Parent, LLC dba Amp Health",
            "letter_date": "2026-02-20",
            "fda_reference": "717992",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dripgym-mobile-parent-llc-dba-amp-health-717992-02202026"
        },
        {
            "company": "FitRX, LLC dba FitRx",
            "letter_date": "2026-02-20",
            "fda_reference": "717987",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-fitrx-717987-02202026"
        },
        {
            "company": "Genesis Health International Inc. dba Genesis",
            "letter_date": "2026-02-20",
            "fda_reference": "721451",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genesis-health-international-inc-dba-genesis-721451-02202026"
        },
        {
            "company": "Good Girl LLC dba GoodGirlRX",
            "letter_date": "2026-02-20",
            "fda_reference": "721449",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/good-girl-llc-dba-goodgirlrx-721449-02202026"
        },
        {
            "company": "Ivim Services LLC dba Ivim",
            "letter_date": "2026-02-20",
            "fda_reference": "721816",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivim-services-llc-dba-ivim-721816-02202026"
        },
        {
            "company": "Join Josie",
            "letter_date": "2026-02-20",
            "fda_reference": "717986",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/join-josie-717986-02202026"
        },
        {
            "company": "Kare Solutions, LLC dba Zappy",
            "letter_date": "2026-02-20",
            "fda_reference": "717991",
            "products": [
                "liraglutide",
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kare-solutions-llc-dba-zappy-717991-02202026"
        },
        {
            "company": "Kin Meds",
            "letter_date": "2026-02-20",
            "fda_reference": "721450",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kin-meds-721450-02202026"
        },
        {
            "company": "Lean Rx, Inc. dba SkinnyRx",
            "letter_date": "2026-02-20",
            "fda_reference": "717989",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-rx-inc-dba-skinnyrx-717989-02202026"
        },
        {
            "company": "Levity Inc. dba Levity",
            "letter_date": "2026-02-20",
            "fda_reference": "717990",
            "products": [
                "liraglutide",
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/levity-inc-dba-levity-717990-02202026"
        },
        {
            "company": "MEDVi, LLC dba MEDVi",
            "letter_date": "2026-02-20",
            "fda_reference": "721455",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-02202026"
        },
        {
            "company": "MaxLife Technologies Inc. dba Maxlife",
            "letter_date": "2026-02-20",
            "fda_reference": "721453",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maxlife-technologies-inc-dba-maxlife-721453-02202026"
        },
        {
            "company": "NewSelf Limited dba NewSelf",
            "letter_date": "2026-02-20",
            "fda_reference": "721472",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/newself-limited-dba-newself-721472-02202026"
        },
        {
            "company": "Newman Clinic, PLLC dba Newman Clinic",
            "letter_date": "2026-02-20",
            "fda_reference": "721470",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/newman-clinic-pllc-dba-newman-clinic-721470-02202026"
        },
        {
            "company": "Peaks Curative, LLC dba Peaks",
            "letter_date": "2026-02-20",
            "fda_reference": "721817",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peaks-curative-llc-dba-peaks-721817-02202026"
        },
        {
            "company": "PharmaZee",
            "letter_date": "2026-02-20",
            "fda_reference": "721473",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmazee-721473-02202026"
        },
        {
            "company": "Premium Health Management Inc. dba Premium Health",
            "letter_date": "2026-02-20",
            "fda_reference": "721474",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/premium-health-management-inc-dba-premium-health-721474-02202026"
        },
        {
            "company": "Refills Health, LLC dba Refills Health",
            "letter_date": "2026-02-20",
            "fda_reference": "721475",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/refills-health-llc-dba-refills-health-721475-02202026"
        },
        {
            "company": "Strut Health, LLC dba Strut",
            "letter_date": "2026-02-20",
            "fda_reference": "721448",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-02202026"
        },
        {
            "company": "Viv Health, Inc. dba VIV RX",
            "letter_date": "2026-02-20",
            "fda_reference": "721818",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viv-health-inc-dba-viv-rx-721818-02202026"
        },
        {
            "company": "Weightless Medical LLC dba WeightCare",
            "letter_date": "2026-02-20",
            "fda_reference": "721478",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "misbranding",
                "other"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/weightless-medical-llc-dba-weightcare-721478-02202026"
        },
        {
            "company": "Zeuss LLC dba Zeuss",
            "letter_date": "2026-02-20",
            "fda_reference": "717985",
            "products": [
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "other",
                "safety-efficacy-claim"
            ],
            "wave": "2026-02",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zeuss-llc-dba-zeuss-717985-02202026"
        },
        {
            "company": "ASN-LABS",
            "letter_date": "2025-09-09",
            "fda_reference": "716459",
            "products": [
                "retatrutide",
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/asn-labs-716459-09092025"
        },
        {
            "company": "All American Wellness",
            "letter_date": "2025-09-09",
            "fda_reference": "715991",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/all-american-wellness-715991-09092025"
        },
        {
            "company": "Amazing Meds",
            "letter_date": "2025-09-09",
            "fda_reference": "715506",
            "products": [
                "retatrutide",
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazing-meds-715506-09092025"
        },
        {
            "company": "Bioverse, Inc. dba Bioverse",
            "letter_date": "2025-09-09",
            "fda_reference": "716508",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bioverse-inc-dba-bioverse-716508-09092025"
        },
        {
            "company": "Body Good Studio",
            "letter_date": "2025-09-09",
            "fda_reference": "716460",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/body-good-studio-716460-09092025"
        },
        {
            "company": "Canada Med Stop",
            "letter_date": "2025-09-09",
            "fda_reference": "716517",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/canada-med-stop-716517-09092025"
        },
        {
            "company": "Cosmo Medical Spa dba Cosmo Med Spa",
            "letter_date": "2025-09-09",
            "fda_reference": "715873",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmo-medical-spa-dba-cosmo-med-spa-715873-09092025"
        },
        {
            "company": "Curex",
            "letter_date": "2025-09-09",
            "fda_reference": "716821",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/curex-716821-09092025"
        },
        {
            "company": "Dr. Gater\u2019s Weight Loss & Wellness",
            "letter_date": "2025-09-09",
            "fda_reference": "712866",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-gaters-weight-loss-wellness-712866-09092025"
        },
        {
            "company": "EA WORKS Limited Liability Company dba Trust Labs",
            "letter_date": "2025-09-09",
            "fda_reference": "715798",
            "products": [
                "retatrutide",
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ea-works-limited-liability-company-dba-trust-labs-715798-09092025"
        },
        {
            "company": "Elevate Your Wellness LLC, dba Elevated",
            "letter_date": "2025-09-09",
            "fda_reference": "719811",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "personalized-dosing-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elevate-your-wellness-llc-dba-elevated-719811-09092025"
        },
        {
            "company": "Elite Health Center",
            "letter_date": "2025-09-09",
            "fda_reference": "715869",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elite-health-center-715869-09092025"
        },
        {
            "company": "EvoLife Wellness",
            "letter_date": "2025-09-09",
            "fda_reference": "715507",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evolife-wellness-715507-09092025"
        },
        {
            "company": "Expert Aesthetics",
            "letter_date": "2025-09-09",
            "fda_reference": "715796",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/expert-aesthetics-715796-09092025"
        },
        {
            "company": "FWD Care, Inc. dba FWD",
            "letter_date": "2025-09-09",
            "fda_reference": "716696",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fwd-care-inc-dba-fwd-716696-09092025"
        },
        {
            "company": "Fancy Meds, LLC dba Fancy Meds",
            "letter_date": "2025-09-09",
            "fda_reference": "716487",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancy-meds-llc-dba-fancy-meds-716487-09092025"
        },
        {
            "company": "FitRX, LLC dba Zealthy",
            "letter_date": "2025-09-09",
            "fda_reference": "716501",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-zealthy-716501-09092025"
        },
        {
            "company": "GLP-1 Solution",
            "letter_date": "2025-09-09",
            "fda_reference": "715883",
            "products": [
                "retatrutide",
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glp-1-solution-715883-09092025"
        },
        {
            "company": "GenLabMeds",
            "letter_date": "2025-09-09",
            "fda_reference": "713650",
            "products": [
                "retatrutide",
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genlabmeds-713650-09092025"
        },
        {
            "company": "Get.Fit.Medical, LLC dba Get.Fit.Medical",
            "letter_date": "2025-09-09",
            "fda_reference": "715801",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/getfitmedical-llc-dba-getfitmedical-715801-09092025"
        },
        {
            "company": "HealBerry",
            "letter_date": "2025-09-09",
            "fda_reference": "719809",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healberry-719809-09092025"
        },
        {
            "company": "Healthon Inc. dba Healthon",
            "letter_date": "2025-09-09",
            "fda_reference": "719809",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthon-inc-dba-healthon-719809-09092025"
        },
        {
            "company": "Healthy Living Clinic",
            "letter_date": "2025-09-09",
            "fda_reference": null,
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-living-clinic-09092025"
        },
        {
            "company": "Healthy Male",
            "letter_date": "2025-09-09",
            "fda_reference": "716506",
            "products": [
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-male-716506-09092025"
        },
        {
            "company": "Hims & Hers Health, Inc. dba Hers",
            "letter_date": "2025-09-09",
            "fda_reference": "716825",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-09092025"
        },
        {
            "company": "Hims & Hers Health, Inc. dba Hims",
            "letter_date": "2025-09-09",
            "fda_reference": "716567",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-09092025"
        },
        {
            "company": "Intimate Rose",
            "letter_date": "2025-09-09",
            "fda_reference": "716458",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intimate-rose-716458-09092025"
        },
        {
            "company": "Invigorate Med Spa",
            "letter_date": "2025-09-09",
            "fda_reference": "715872",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/invigorate-med-spa-715872-09092025"
        },
        {
            "company": "JulyMD",
            "letter_date": "2025-09-09",
            "fda_reference": "716828",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/julymd-716828-09092025"
        },
        {
            "company": "Las Villas Health Care LLC dba Villas Health",
            "letter_date": "2025-09-09",
            "fda_reference": "716504",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/las-villas-health-care-llc-dba-villas-health-716504-09092025"
        },
        {
            "company": "Lean Dreams LLC dba LeanDreams",
            "letter_date": "2025-09-09",
            "fda_reference": "716697",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-dreams-llc-dba-leandreams-716697-09092025"
        },
        {
            "company": "Lovely Meds, Inc. dba Lovely Meds",
            "letter_date": "2025-09-09",
            "fda_reference": "716829",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovely-meds-inc-dba-lovely-meds-716829-09092025"
        },
        {
            "company": "Lumimeds",
            "letter_date": "2025-09-09",
            "fda_reference": "716510",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lumimeds-716510-09092025"
        },
        {
            "company": "Lyfe Rx",
            "letter_date": "2025-09-09",
            "fda_reference": null,
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lyfe-rx-09092025"
        },
        {
            "company": "Mane & Steel, LLC. dba Mane & Steel",
            "letter_date": "2025-09-09",
            "fda_reference": "716455",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mane-steel-llc-dba-mane-steel-716455-09092025"
        },
        {
            "company": "Master Pharmaceuticals Group",
            "letter_date": "2025-09-09",
            "fda_reference": "715800",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/master-pharmaceuticals-group-715800-09092025"
        },
        {
            "company": "Matthew Stern, CEO MyStart Health LLC.",
            "letter_date": "2025-09-09",
            "fda_reference": "714755",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/matthew-stern-ceo-mystart-health-llc-714755-09092025"
        },
        {
            "company": "MedClub by Dr. Jenn",
            "letter_date": "2025-09-09",
            "fda_reference": "712126",
            "products": [
                "retatrutide",
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "unapproved-new-drug"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medclub-dr-jenn-712126-09092025"
        },
        {
            "company": "Nuvo Life Health Inc. dba Nuvo Life Health",
            "letter_date": "2025-09-09",
            "fda_reference": "715794",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuvo-life-health-inc-dba-nuvo-life-health-715794-09092025"
        },
        {
            "company": "Remedy Meds",
            "letter_date": "2025-09-09",
            "fda_reference": "716830",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025"
        },
        {
            "company": "Reset IV, LLC dba Reset IV",
            "letter_date": "2025-09-09",
            "fda_reference": "716488",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/reset-iv-llc-dba-reset-iv-716488-09092025"
        },
        {
            "company": "SemaBio",
            "letter_date": "2025-09-09",
            "fda_reference": "715866",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/semabio-715866-09092025"
        },
        {
            "company": "SimpleRx",
            "letter_date": "2025-09-09",
            "fda_reference": "715874",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/simplerx-715874-09092025"
        },
        {
            "company": "Slendid",
            "letter_date": "2025-09-09",
            "fda_reference": "716700",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/slendid-716700-09092025"
        },
        {
            "company": "Sprout Health Partners LLC dba Sprout Health",
            "letter_date": "2025-09-09",
            "fda_reference": "715879",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sprout-health-partners-llc-dba-sprout-health-715879-09092025"
        },
        {
            "company": "TRYM Health, Inc. dba TRYM Health",
            "letter_date": "2025-09-09",
            "fda_reference": "716699",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trym-health-inc-dba-trym-health-716699-09092025"
        },
        {
            "company": "The HCG Institute",
            "letter_date": "2025-09-09",
            "fda_reference": "716512",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "safety-efficacy-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hcg-institute-716512-09092025"
        },
        {
            "company": "Try Nova",
            "letter_date": "2025-09-09",
            "fda_reference": "716695",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/try-nova-716695-09092025"
        },
        {
            "company": "Tuyo Health, Inc. dba Tuyo Health",
            "letter_date": "2025-09-09",
            "fda_reference": "716502",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tuyo-health-inc-dba-tuyo-health-716502-09092025"
        },
        {
            "company": "Vitals RX",
            "letter_date": "2025-09-09",
            "fda_reference": "715868",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitals-rx-715868-09092025"
        },
        {
            "company": "directmeds.com, Inc. dba DirectMeds",
            "letter_date": "2025-09-09",
            "fda_reference": "716822",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison",
                "personalized-dosing-claim"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/directmedscom-inc-dba-directmeds-716822-09092025"
        },
        {
            "company": "eDrugstore",
            "letter_date": "2025-09-09",
            "fda_reference": "716505",
            "products": [
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/edrugstore-716505-09092025"
        },
        {
            "company": "iVisitDoc, Inc. dba iVisitDoc",
            "letter_date": "2025-09-09",
            "fda_reference": "716826",
            "products": [
                "semaglutide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivisitdoc-inc-dba-ivisitdoc-716826-09092025"
        },
        {
            "company": "inspire.clinic",
            "letter_date": "2025-09-09",
            "fda_reference": "715799",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/inspireclinic-715799-09092025"
        },
        {
            "company": "ybycmeds",
            "letter_date": "2025-09-09",
            "fda_reference": "715878",
            "products": [
                "semaglutide",
                "tirzepatide"
            ],
            "cited_violations": [
                "fda-approved-claim",
                "misbranding",
                "misleading-comparison"
            ],
            "wave": "2025-09",
            "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ybycmeds-715878-09092025"
        }
    ]
}